meningioma lawsuit

The Depo-Provera Rule 702 hearing on general causation moves to July 27, 2026. Here's what the ruling could mean if your case isn't covered by the settlement.

Depo-Provera MDL No. 3140 Update Depo-Provera Daubert Hearing 2026: June 24 Date, 6,000 Cases and What It Means The Depo-Provera Daubert hearing scheduled for June 24–26, 2026 is a pivotal Rule 702 hearing in the federal meningioma litigation against Pfizer and related defendants. With roughly 6,000 filed or reported claims tied to Depo-Provera and [...]

Short answer: Depo-Provera (medroxyprogesterone acetate) has been linked to an elevated risk of intracranial meningioma — a type of brain tumor. Over 12,000 lawsuits have been filed against Pfizer as of 2026, consolidated into a federal MDL in the Northern District of Illinois. Women who used Depo-Provera for one year or more and later developed [...]

Breaking Depo-Provera lawsuit update: Pfizer files Daubert motion in the meningioma MDL ahead of June 24–26 causation hearings. 3,790 plaintiffs, settlement estimates $100K–$1.5M, who qualifies in 2026. Call 1 (855) 664-8713 for a free case review.

Get the latest Depo-Provera lawsuit update: 1,775+ MDL cases, meningioma risks, eligibility, settlements & how to join now.